Bio-Rad Laboratories, Inc. (NYSE: BIO and BIOb), was founded in 1952 in Berkeley, California. The company was initially engaged in the development and production of specialty chemicals used in biochemical, pharmaceutical, and other life science research applications. Today, Bio-Rad manufactures and supplies life science research, healthcare, analytical chemistry, and other markets with products and systems used to separate complex chemical and biological materials and to identify, analyze, and purify their components.[1]
Bio-Rad operates in two industry segments: Life Science Research and Clinical Diagnostics. Both segments operate worldwide. Bio-Rad’s customers include hospitals, universities, major research institutions, and biotechnology and pharmaceutical companies. Bio-Rad’s headquarters are in Hercules, California. The company has offices and facilities worldwide and more than 6,800 employees. Bio-Rad had revenues of more than $1.7 billion in 2008. The company has been listed on the New York Stock Exchange since October 24, 2008. Before that, Bio-Rad was listed on the American Stock Exchange.
Life science is the study of the characteristics, behavior, and structure of living organisms and their component systems. Life science researchers use a variety of products and systems — including reagents, instruments, software, and apparatus — to advance drug discovery, biotechnology, food pathogen testing, and the study of life processes, primarily within a laboratory setting. Bio-Rad’s products are based on technologies used to separate, purify, identify, analyze, and amplify biological and chemical materials.
Bio-Rad ranks among the top five life science companies in the world and maintains a solid reputation for quality and innovation. The Life Science Group provides a wide range of laboratory instruments, apparatus, and consumables used for research in functional genomics, proteomics, and food safety. The company holds leadership positions in eletrophoresis, protein assays, BSE (or mad cow disease) and CWD (chronic wasting disease) testing, gel image analysis, DNA amplification, and biochromatography. The primary end users in Bio-Rad’s sectors of the market are universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, and food testing laboratories.
Bio-Rad's Spectroscopy Division (formerly Informatics) specializes in database and software solutions for the scientific community.
Spectral Databases - Over 1.3 Million Spectra, Including Sadtler Data
Bio-Rad is the leading producer and publisher of fully verified spectral databases, with a collection that contains IR, Raman, NIR, NMR, MS, and UV-Vis data covering pure compounds and a broad range of commercial products.
Bio-Rad Laboratories, Inc. (Bio-Rad), incorporated in 1957, manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two industry segments: Life Science and Clinical Diagnostics. On January 6, 2010, Bio-Rad acquired certain diagnostic businesses of Biotest AG.
Life Science Segment
Life science is the study of the characteristics, behavior, and structure of living organisms and their component systems. The primary technological applications that the Company supplies to these segments consist of electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation and amplification. The primary end users in its sectors of the market are universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers and food testing laboratories.
Clinical Diagnostics Segment
The Clinical Diagnostic market encompasses an array of technologies incorporated into a variety of products used to detect, identify, monitor and quantify substances in patient and donor blood or other bodily fluids and tissues. The majority of these tests are performed in-vitro (outside the body). The information generated by these tests helps physicians diagnose disease and guide patient therapy and treatment, all of which helps improve patient care. Consumers of clinical diagnostic products are hospital laboratories, reference laboratories, physician office laboratories, government agencies and diagnostic manufacturers.
Bio-Rad competes with GE Biosciences, Life Technologies, Millipore, Thermo Fisher Scientific, Roche, Abbott Laboratories, Siemens Medical Diagnostics Solutions, Beckman Coulter, Becton-Dickinson, bioMerieux, Johnson & Johnson, Tosoh, Immucor, Cepheid and DiaSorin.
Bio-Rad Laboratories was founded in 1952 by husband and wife team David and Alice Schwartz. The couple first met in a class at the University of California–Berkeley, from which they both graduated.
The idea that launched the company came about unexpectedly during a game of bridge. During the card game, the players, including Dave and Alice, joked about products that were not but maybe should have been on the market. Someone suggested creating tobacco mosaic virus, a virus Alice was using for scientific research and one that required many days to prepare. Dave questioned why no one was manufacturing it. The following day, he and Alice searched their neighborhood in Berkeley for a place to launch a company with a mission to accelerate the scientific discovery process by providing products and tools to researchers.
OVERALL
Beta: 1.16
Market Cap (Mil.): $3,490.63
Shares Outstanding (Mil.): 27.88
Annual Dividend: --
Yield (%): --
FINANCIALS
BIO Industry Sector
P/E (TTM): 18.99 5.56 40.56
EPS (TTM): 26.76 -- --
ROI: 8.33 2.56 1.92
ROE: 13.27 3.75 2.49
Name Age Since Current Position
Schwartz, David 87 2002 Chairman of the Board
Schwartz, Norman 61 2003 President, Chief Executive Officer, Director
Tsingos, Christine 52 2003 Chief Financial Officer, Vice President
Wadler, Sanford 64 1996 Vice President, General Counsel, Secretary
Goetz, John 61 2000 Vice President, Group Manager - Clinical Diagnostics Group
Crutchfield, Bradford 48 2003 Vice President, Group Manager - Life Science Group
Magni, Giovanni 54 2004 Vice President, International Sales Manager
Hutton, Ronald 53 1997 Treasurer
Schwartz, Alice 84 1967 Director
Hillman, Albert 79 1980 Independent Director
Drapeau, Louis 67 2007 Independent Director
Love, Ted 52 2010 Independent Director
COMPANY ADDRESS
Bio Rad Laboratories Inc
1000 Alfred Nobel Drive
Hercules CA 94547
Bio-Rad operates in two industry segments: Life Science Research and Clinical Diagnostics. Both segments operate worldwide. Bio-Rad’s customers include hospitals, universities, major research institutions, and biotechnology and pharmaceutical companies. Bio-Rad’s headquarters are in Hercules, California. The company has offices and facilities worldwide and more than 6,800 employees. Bio-Rad had revenues of more than $1.7 billion in 2008. The company has been listed on the New York Stock Exchange since October 24, 2008. Before that, Bio-Rad was listed on the American Stock Exchange.
Life science is the study of the characteristics, behavior, and structure of living organisms and their component systems. Life science researchers use a variety of products and systems — including reagents, instruments, software, and apparatus — to advance drug discovery, biotechnology, food pathogen testing, and the study of life processes, primarily within a laboratory setting. Bio-Rad’s products are based on technologies used to separate, purify, identify, analyze, and amplify biological and chemical materials.
Bio-Rad ranks among the top five life science companies in the world and maintains a solid reputation for quality and innovation. The Life Science Group provides a wide range of laboratory instruments, apparatus, and consumables used for research in functional genomics, proteomics, and food safety. The company holds leadership positions in eletrophoresis, protein assays, BSE (or mad cow disease) and CWD (chronic wasting disease) testing, gel image analysis, DNA amplification, and biochromatography. The primary end users in Bio-Rad’s sectors of the market are universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers, and food testing laboratories.
Bio-Rad's Spectroscopy Division (formerly Informatics) specializes in database and software solutions for the scientific community.
Spectral Databases - Over 1.3 Million Spectra, Including Sadtler Data
Bio-Rad is the leading producer and publisher of fully verified spectral databases, with a collection that contains IR, Raman, NIR, NMR, MS, and UV-Vis data covering pure compounds and a broad range of commercial products.
Bio-Rad Laboratories, Inc. (Bio-Rad), incorporated in 1957, manufactures and supplies the life science research, healthcare, analytical chemistry and other markets with a range of products and systems used to separate complex chemical and biological materials and to identify, analyze and purify their components. Bio-Rad operates in two industry segments: Life Science and Clinical Diagnostics. On January 6, 2010, Bio-Rad acquired certain diagnostic businesses of Biotest AG.
Life Science Segment
Life science is the study of the characteristics, behavior, and structure of living organisms and their component systems. The primary technological applications that the Company supplies to these segments consist of electrophoresis, image analysis, molecular detection, chromatography, gene transfer, sample preparation and amplification. The primary end users in its sectors of the market are universities and medical schools, industrial research organizations, government agencies, pharmaceutical manufacturers, biotechnology researchers and food testing laboratories.
Clinical Diagnostics Segment
The Clinical Diagnostic market encompasses an array of technologies incorporated into a variety of products used to detect, identify, monitor and quantify substances in patient and donor blood or other bodily fluids and tissues. The majority of these tests are performed in-vitro (outside the body). The information generated by these tests helps physicians diagnose disease and guide patient therapy and treatment, all of which helps improve patient care. Consumers of clinical diagnostic products are hospital laboratories, reference laboratories, physician office laboratories, government agencies and diagnostic manufacturers.
Bio-Rad competes with GE Biosciences, Life Technologies, Millipore, Thermo Fisher Scientific, Roche, Abbott Laboratories, Siemens Medical Diagnostics Solutions, Beckman Coulter, Becton-Dickinson, bioMerieux, Johnson & Johnson, Tosoh, Immucor, Cepheid and DiaSorin.
Bio-Rad Laboratories was founded in 1952 by husband and wife team David and Alice Schwartz. The couple first met in a class at the University of California–Berkeley, from which they both graduated.
The idea that launched the company came about unexpectedly during a game of bridge. During the card game, the players, including Dave and Alice, joked about products that were not but maybe should have been on the market. Someone suggested creating tobacco mosaic virus, a virus Alice was using for scientific research and one that required many days to prepare. Dave questioned why no one was manufacturing it. The following day, he and Alice searched their neighborhood in Berkeley for a place to launch a company with a mission to accelerate the scientific discovery process by providing products and tools to researchers.
OVERALL
Beta: 1.16
Market Cap (Mil.): $3,490.63
Shares Outstanding (Mil.): 27.88
Annual Dividend: --
Yield (%): --
FINANCIALS
BIO Industry Sector
P/E (TTM): 18.99 5.56 40.56
EPS (TTM): 26.76 -- --
ROI: 8.33 2.56 1.92
ROE: 13.27 3.75 2.49
Name Age Since Current Position
Schwartz, David 87 2002 Chairman of the Board
Schwartz, Norman 61 2003 President, Chief Executive Officer, Director
Tsingos, Christine 52 2003 Chief Financial Officer, Vice President
Wadler, Sanford 64 1996 Vice President, General Counsel, Secretary
Goetz, John 61 2000 Vice President, Group Manager - Clinical Diagnostics Group
Crutchfield, Bradford 48 2003 Vice President, Group Manager - Life Science Group
Magni, Giovanni 54 2004 Vice President, International Sales Manager
Hutton, Ronald 53 1997 Treasurer
Schwartz, Alice 84 1967 Director
Hillman, Albert 79 1980 Independent Director
Drapeau, Louis 67 2007 Independent Director
Love, Ted 52 2010 Independent Director
COMPANY ADDRESS
Bio Rad Laboratories Inc
1000 Alfred Nobel Drive
Hercules CA 94547
Last edited: